Highland Capital Management Fund Advisors, L.P. Coherus Bio Sciences, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $43,260 - $64,170	-3,000 Reduced 7.5%	37,000 $541,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $496,799 - $568,200	-30,000 Reduced 42.86%	40,000 $695,000
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $737,922 - $843,037	-42,385 Reduced 37.71%	70,000 $1.28 Million
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $72,150 - $95,800	-5,000 Reduced 4.26%	112,385 $2.01 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $86,824 - $167,623	-7,440 Reduced 5.96%	117,385 $1.9 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $2.03 Million - $2.92 Million	124,825 New	124,825 $2.53 Million

Others Institutions Holding CHRS

# of Institutions

132

Shares Held

77.3M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$13.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$12.7 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$11.6 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$3.4 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$3.2 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.1M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account